Furthermore, CAFs may alter the anti‐tumor immune response through secretion of several immune modulators such as IL6, CCL2, CXCL12, and TGFβ2 [37], which we found to be up‐regulated in CMS4 PM. The gene discussed is CCL2; the disease is neoplasm.